• About us
• Contact

Advertisement

Organisation › Details

Advalytix AG

Advalytix AG (Munich) was founded in 2000 and has been a wholly owned subsidiary of Olympus Life and Material Science Europa GmbH since 2005. Within the Olympus Group, Advalytix is the world wide centre of expertise for cell-based molecular diagnostics. One of the company's main focuses is the miniaturisation of diagnostic and biological tests for research and development.

Advalytix products uniquely link imaging technologies such as microscopy with nucleic acid analysis, enabling Advalytix to offer turnkey system solutions consisting of both instruments and reagents. Advalytix has developed a portfolio of products for these applications, based on proprietary microelectronics technologies, such as surface acoustic waves (SAW). *

 

	Start	2000-11-03 splitoff
	End	2005-04-04 renamed data ca.
	Group	Danaher (Group)
	Today	Beckman Coulter Biomedical GmbH (Advalytix)
	Successor	Olympus Life Science Research Europa GmbH (Advalytix)
	Industry	lab-on-a-chip technology
	Region	München (Munich)
	Country	Germany
	Street	50 Sauerbruchstr.
	City	81377 München
	Tel	+49-89-579589-3540
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-12-30

Advertisement

More documents for Danaher (Group)

• [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
• [4] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
• [5] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
• [6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
• [7] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
• [8] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
• [9] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
• [10] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.